Nomura Holdings Inc Vertex Pharmaceuticals Inc Call Options Transaction History

Nomura Holdings Inc

  • $41.1 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$460.0 - $505.78 $4.51 Million - $4.96 Million
9,800 Added 65.33%
24,800 $11.5 Million
Q2 2024

Aug 14, 2024
BUY
$392.81 - $485.53 $3.54 Million - $4.37 Million
9,000 Added 150.0%
15,000 $7.03 Million
Q1 2024

May 15, 2024
BUY
$407.69 - $446.08 $2.45 Million - $2.68 Million
6,000 New
6,000 $2.51 Million
Q1 2018

May 14, 2018
BUY
$151.6 - $177.13 $26.7 Million - $31.2 Million
176,400 New
176,400 $28.7 Million

Others Institutions Holding VRTX

# of Institutions
1,724
Shares Held
222M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Nomura Holdings Inc Portfolio

Follow Nomura Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email